Approval · Notice of Compliance 19517 · 2017
MACROBID: Notice of Compliance 19517
Issued July 10, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19517
- Date
- July 10, 2017
- Company
- Allergan Pharma Co.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Manufacturer name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MACROBID | 02063662 | Cancelled Post Market |
Medicinal ingredients
- NITROFURANTOIN 100 MG per CAP